期刊文献+

2010-2012年我院质子泵抑制剂的使用分析 被引量:3

Analysis of proton pump inhibitors used in ours hospital during 2010-2012
下载PDF
导出
摘要 目的对该院质子泵抑制剂的使用情况进行分析,为促进合理用药,提高临床疗效,有效降低药品费用提供参考依据。方法对2010-2012年医院住院患者的用药频度(DDDs)、日均费用(DDDc)、销售金额进行分析。结果该院质子泵抑制剂的使用频率和用药金额呈快速上升趋势,其中奥美拉唑的DDDs与销售金额始终排在首位。大部分品种的销售金额与用药数同步性良好。结论按照合理用药原则,应尽量首选国家基本药物,该院目前PPI的选择主要还是第1代PPI,药物的使用具有合理性。 Objective To analyze the application of proton pump inhibitors (PPIs) in our hospital in order to provide references for rational use of PPIs and reduce the cost in clinical practice. Methods The amount of drugs consumption sum, defined daily doses (DDDs) and defined daily consumption (DDDc) of PPIs in our hospital during 2010 -2012 were analyzed statistically. Results The consumption sum and DDDs of PPI maintained rapid growth during 2010 - 2012 and omeprazole took up the first place in the fist of PPIs. The consumption and DDDs maintained synchronization in most varieties of PPI. Con- duslon According to the principle of rational drug use, national essential drugs should be used as the first choice in clinical practice. So the first generation of PPIs was used mostly in our hospital and the application of PPIs was basically rational.
机构地区 广东省中医院
出处 《临床合理用药杂志》 2013年第29期26-27,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 质子泵抑制剂 用药频度(DDDs) 日均费用(DDDc) Proton pump inhibitors DDDs DDDc
  • 相关文献

参考文献5

二级参考文献24

  • 1高英丽,朱京慈.颅脑损伤后应激性溃疡的发病机制及预防[J].中华创伤杂志,2005,21(6):478-479. 被引量:65
  • 2李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
  • 3Baldi F. Lansoprazole ora-dispersible tablet :pharmacokinetics and therapeutic use in acid-ralated disorders. Drugs,2005,65:1419-1426. 被引量:1
  • 4Andersson T, Hss RK, Bredberg E,et al. Pharmacokinetics and pharmacodynamics of esomeprazole,the S-isomer of omeprazole. Aliment Pharmacol Ther,2001,15 : 1563-1559. 被引量:1
  • 5Wilder-Smith CH, Rohss K, Nilsson-Pieschl C, et al. Esomeprazole 40 mg Provides Improved Intragastric Acid Control as Compared with Lansoprazole 30 mg and Rabeprazole 20 mg in Healthy Volunteers. Digestion ,2003,68:184-188. 被引量:1
  • 6Li XQ, Andersso TB,Ahlstrom M,et al. Comparison of inhibitory effects of the proton pump-inhibitory drugs omeprazole, asomeprazole, lansoprazole,pantoprazole,and rabeprazole on human cytochrome P450 activities. DMD,2004,32:821-827. 被引量:1
  • 7Rohss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg,pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms, Eur J Clin Pharmacol, 2004,60 : 531 - 539. 被引量:1
  • 8Takahashi S, Yamazaki T, Okabe S. Leminoprazole protects cultured gastric mucosal cells against damage caused by ethanol, indometacin and taurocholate. Pharmacology, 1997,54 : 118-126. 被引量:1
  • 9Takahashi S, Okabe S. Mechanism by which orally administered leminoprazole stimulates mucus synthesis in rats. Pharmacology, 1998,57:47-56. 被引量:1
  • 10Galmiche JP, Broley Des Varannes S, et al. Tenatoprazole, a novel proton pump inhibitor with a rolonged plasma half-life:effects on intragastric pH and comparison with esomeprazole in healthy volunteers. Aliment Pharmacol Ther,2004,19:655-662. 被引量:1

共引文献25

同被引文献28

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部